POS0626 RADIOFREQUENCY ECHOGRAPHIC MULTISPECTROMETRY (REMS): A NONINVASIVE TECHNOLOGY FOR MUSCLE ASSESSMENT IN SYSTEMIC SCLEROSIS

In systemic sclerosis (SSc), the common musculoskeletal involvement significantly affects patients' quality of life and markedly increases the disability rate. Therefore, investigating muscle health in this patient population represents an important step toward improving overall quality of life through the timely diagnosis of muscle damage, facilitating early fracture prevention and the personalization of therapeutic strategies. In this context, the use of a safe and non-invasive technology, such as Radiofrequency Echographic Multi-Spectrometry (REMS), may be crucial for optimal patient management. REMS is widely used for the assessment of bone health status and has recently been introduced for the evaluation of muscle health status.